Literature DB >> 22663551

Five-year change in morphological and functional alterations of the thyroid gland: the Study of Health in Pomerania.

Henry Völzke1, Till Ittermann, Martin Albers, Nele Friedrich, Matthias Nauck, Harald Below, Axel Kramer.   

Abstract

BACKGROUND: While cross-sectional data on thyroid epidemiology are common, few longitudinal data on the incidence and progression of thyroid disorders exist. The aim of this study was to analyze the 5-year change and the incidence of morphological and functional alterations of the thyroid gland in a previously iodine-deficient area.
METHODS: We used 5-year follow-up data based on 2941 participants (20-79 years) of the population-based Study of Health in Pomerania. The thyroid structure and size were measured by ultrasonography. Thyroid function and serum autoantibodies to thyroperoxidase (anti-TPO-Ab) were evaluated.
RESULTS: During follow-up, the median iodine/creatinine ratio decreased slightly from 134.2 to 130.4 μg/g. The mean thyroid volume was nonsignificantly increased by 0.73 mL [confidence interval (CI) -1.68-3.41 mL]. The incidence rate of goiter was 34.0 [CI 30.7-37.7] per 1000 person-years (py), the incident rate of nodules was 16.6 [CI 14.5-19.1] per 1000 py. Median serum thyrotropin levels increased slightly (0.10 [CI -0.10-0.34 mIU/L]). The incidence of positive anti-TPO-Ab was 3.4 [CI 2.6-4.7] per 1000 py. For all thyroid parameters, the regression rates were higher than the incidence rates.
CONCLUSIONS: After iodine fortification became effective in this previously iodine-deficient region, there is a negative net balance between occurring and reverting goiter and nodules. Along with balanced incidences of hyper- and hypothyroid dysfunction and the low incidence of autoimmune-related findings, these findings indicate that the current iodine status is sufficient to prevent iodine deficiency-related disorders in the adult population of the study region.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22663551     DOI: 10.1089/thy.2011.0525

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China.

Authors:  B Ren; S Wan; L Liu; M Qu; H Wu; H Shen
Journal:  J Endocrinol Invest       Date:  2020-08-20       Impact factor: 4.256

Review 2.  [Autoimmune diseases of the thyroid gland].

Authors:  S Allelein; J Feldkamp; M Schott
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

3.  Risk-Benefit Assessment of an Increase in the Iodine Fortification Level of Foods in Denmark-A Pilot Study.

Authors:  Lea Sletting Jakobsen; Josefine Ostenfeld Nielsen; Sophie Egesø Paulsen; Malene Outzen; Allan Linneberg; Line Tang Møllehave; Tue Christensen; Gitte Ravn-Haren
Journal:  Foods       Date:  2022-04-28

Review 4.  Euthyroid goiter with and without nodules--diagnosis and treatment.

Authors:  Dagmar Führer; Andreas Bockisch; Kurt Werner Schmid
Journal:  Dtsch Arztebl Int       Date:  2012-07-23       Impact factor: 5.594

5.  Monitoring the prevalence of thyroid disorders in the adult population of Northeast Germany.

Authors:  Rehman Mehmood Khattak; Till Ittermann; Matthias Nauck; Harald Below; Henry Völzke
Journal:  Popul Health Metr       Date:  2016-11-08

6.  Incidence of thyroid dysfunction in an Iranian adult population: the predictor role of thyroid autoantibodies: results from a prospective population-based cohort study.

Authors:  Ashraf Aminorroaya; Rokhsareh Meamar; Massoud Amini; Awat Feizi; Azamosadat Tabatabae; Elham Faghih Imani
Journal:  Eur J Med Res       Date:  2017-06-21       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.